169 related articles for article (PubMed ID: 31945397)
1. Naturally occurring cinnamic acid derivatives prevent amyloid transformation of alpha-synuclein.
Medvedeva M; Barinova K; Melnikova A; Semenyuk P; Kolmogorov V; Gorelkin P; Erofeev A; Muronetz V
Biochimie; 2020 Mar; 170():128-139. PubMed ID: 31945397
[TBL] [Abstract][Full Text] [Related]
2. Hydroxycinnamic Acid Derivatives from Coffee Extracts Prevent Amyloid Transformation of Alpha-Synuclein.
Medvedeva M; Kitsilovskaya N; Stroylova Y; Sevostyanova I; Saboury AA; Muronetz V
Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140356
[TBL] [Abstract][Full Text] [Related]
3. Quinolinic Acid Amyloid-like Fibrillar Assemblies Seed α-Synuclein Aggregation.
Tavassoly O; Sade D; Bera S; Shaham-Niv S; Vocadlo DJ; Gazit E
J Mol Biol; 2018 Oct; 430(20):3847-3862. PubMed ID: 30098337
[TBL] [Abstract][Full Text] [Related]
4. Influence of the β-sheet content on the mechanical properties of aggregates during amyloid fibrillization.
Ruggeri FS; Adamcik J; Jeong JS; Lashuel HA; Mezzenga R; Dietler G
Angew Chem Int Ed Engl; 2015 Feb; 54(8):2462-6. PubMed ID: 25588987
[TBL] [Abstract][Full Text] [Related]
5. α-Synuclein Dimers as Potent Inhibitors of Fibrillization.
Kyriukha YA; Afitska K; Kurochka AS; Sachan S; Galkin M; Yushchenko DA; Shvadchak VV
J Med Chem; 2019 Nov; 62(22):10342-10351. PubMed ID: 31625739
[TBL] [Abstract][Full Text] [Related]
6. α-Synuclein aggregation at low concentrations.
Afitska K; Fucikova A; Shvadchak VV; Yushchenko DA
Biochim Biophys Acta Proteins Proteom; 2019; 1867(7-8):701-709. PubMed ID: 31096048
[TBL] [Abstract][Full Text] [Related]
7. Structural Optimization of Inhibitors of α-Synuclein Fibril Growth: Affinity to the Fibril End as a Crucial Factor.
Afitska K; Priss A; Yushchenko DA; Shvadchak VV
J Mol Biol; 2020 Feb; 432(4):967-977. PubMed ID: 31809698
[TBL] [Abstract][Full Text] [Related]
8. Natural and Synthetic Derivatives of Hydroxycinnamic Acid Modulating the Pathological Transformation of Amyloidogenic Proteins.
Muronetz VI; Barinova K; Kudryavtseva S; Medvedeva M; Melnikova A; Sevostyanova I; Semenyuk P; Stroylova Y; Sova M
Molecules; 2020 Oct; 25(20):. PubMed ID: 33053854
[TBL] [Abstract][Full Text] [Related]
9. Gallic acid interacts with α-synuclein to prevent the structural collapse necessary for its aggregation.
Liu Y; Carver JA; Calabrese AN; Pukala TL
Biochim Biophys Acta; 2014 Sep; 1844(9):1481-5. PubMed ID: 24769497
[TBL] [Abstract][Full Text] [Related]
10. Modification by glyceraldehyde-3-phosphate prevents amyloid transformation of alpha-synuclein.
Barinova K; Serebryakova M; Sheval E; Schmalhausen E; Muronetz V
Biochim Biophys Acta Proteins Proteom; 2019 Apr; 1867(4):396-404. PubMed ID: 30639428
[TBL] [Abstract][Full Text] [Related]
11. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.
Conway KA; Harper JD; Lansbury PT
Biochemistry; 2000 Mar; 39(10):2552-63. PubMed ID: 10704204
[TBL] [Abstract][Full Text] [Related]
12. Polyphenols in combination with β-cyclodextrin can inhibit and disaggregate α-synuclein amyloids under cell mimicking conditions: A promising therapeutic alternative.
Gautam S; Karmakar S; Batra R; Sharma P; Pradhan P; Singh J; Kundu B; Chowdhury PK
Biochim Biophys Acta Proteins Proteom; 2017 May; 1865(5):589-603. PubMed ID: 28238838
[TBL] [Abstract][Full Text] [Related]
13. Ionic liquids promote amyloid formation from alpha-synuclein.
Hwang H; Choi H; Kim HK; Jo DH; Kim TD
Anal Biochem; 2009 Mar; 386(2):293-5. PubMed ID: 19135970
[TBL] [Abstract][Full Text] [Related]
14. Tryptophan-cardanol fluorescent nanoparticles inhibit α-synuclein aggregation and disrupt amyloid fibrils.
Sunny LP; Srikanth P; Sunitha AK; Tembulkar N; Abraham JN
J Pept Sci; 2022 Apr; 28(4):e3374. PubMed ID: 34651357
[TBL] [Abstract][Full Text] [Related]
15. Synergistic Amyloid Switch Triggered by Early Heterotypic Oligomerization of Intrinsically Disordered α-Synuclein and Tau.
Bhasne K; Sebastian S; Jain N; Mukhopadhyay S
J Mol Biol; 2018 Aug; 430(16):2508-2520. PubMed ID: 29704492
[TBL] [Abstract][Full Text] [Related]
16. Defining α-synuclein species responsible for Parkinson's disease phenotypes in mice.
Froula JM; Castellana-Cruz M; Anabtawi NM; Camino JD; Chen SW; Thrasher DR; Freire J; Yazdi AA; Fleming S; Dobson CM; Kumita JR; Cremades N; Volpicelli-Daley LA
J Biol Chem; 2019 Jul; 294(27):10392-10406. PubMed ID: 31142553
[TBL] [Abstract][Full Text] [Related]
17. Phenolic compounds prevent the oligomerization of α-synuclein and reduce synaptic toxicity.
Takahashi R; Ono K; Takamura Y; Mizuguchi M; Ikeda T; Nishijo H; Yamada M
J Neurochem; 2015 Sep; 134(5):943-55. PubMed ID: 26016728
[TBL] [Abstract][Full Text] [Related]
18. The neurotransmitter serotonin interrupts α-synuclein amyloid maturation.
Falsone SF; Leitinger G; Karner A; Kungl AJ; Kosol S; Cappai R; Zangger K
Biochim Biophys Acta; 2011 May; 1814(5):553-61. PubMed ID: 21376144
[TBL] [Abstract][Full Text] [Related]
19. Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro.
Köppen J; Schulze A; Machner L; Wermann M; Eichentopf R; Guthardt M; Hähnel A; Klehm J; Kriegeskorte MC; Hartlage-Rübsamen M; Morawski M; von Hörsten S; Demuth HU; Roßner S; Schilling S
Molecules; 2020 Jan; 25(3):. PubMed ID: 32013170
[TBL] [Abstract][Full Text] [Related]
20. Effects of phosphatidylcholine membrane fluidity on the conformation and aggregation of N-terminally acetylated α-synuclein.
O'Leary EI; Jiang Z; Strub MP; Lee JC
J Biol Chem; 2018 Jul; 293(28):11195-11205. PubMed ID: 29853639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
